FURONTEER (370090) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Jul, 2026Executive summary
Operates two main divisions: equipment for automotive camera assembly/testing and core automation components.
2024 revenue was KRW 25.3 billion, down 45.6% year-over-year, with a sharp drop in both equipment and component sales.
Net income for 2024 was KRW 62 million, a 99.2% decrease from 2023, mainly due to a significant decline in operating profit.
The company remains financially stable with a strong equity base and low debt ratio.
Financial highlights
2024 revenue: KRW 25.3 billion (2023: KRW 46.5 billion; 2022: KRW 26.9 billion).
Operating loss: KRW -3.75 billion (2023: profit of KRW 7.16 billion).
Net income: KRW 62 million (2023: KRW 7.52 billion).
Gross margin: 31.3% (2023: 38.4%).
Cash and equivalents at year-end: KRW 12.4 billion (2023: KRW 35.3 billion).
Equity ratio: 93.4%; debt ratio: 7.1%.
Outlook and guidance
Management expects continued demand for automotive and industrial camera solutions, but notes market volatility and investment delays among major customers.
No specific quantitative guidance provided for 2025.
Latest events from FURONTEER
- 2026 H1 revenue reached KRW 12.0B with a net loss of KRW 1.26B, but outlook remains growth-focused.370090
Q2 2026 - Q3 revenue and profit dropped sharply YoY, but R&D and future growth prospects remain strong.370090
Q3 2024 - H1 2024 revenue was ₩19.8B, net profit ₩3.77B, with strong growth prospects in ADAS and LiDAR.370090
Q2 2024 - Q1 2025 posted a net loss amid weak automotive demand, but R&D investment remains strong.370090
Q1 2025 - 2025 revenue dropped 52% with a net loss of KRW 6.15 billion amid weak equipment sales.370090
Q4 2025 - Q1 2026 revenue dropped sharply with ongoing losses, but cash and equity remain strong.370090
Q1 2026 - Q3 2025 saw steep revenue and profit declines, but cash and leverage remain stable.370090
Q3 2025 - 2025 H1 saw steep revenue and profit declines, but the company remains well-capitalized and focused on R&D.370090
Q2 2025